🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

Recruitingn/aAges 18 Years - anyAllAgendia
NCT03053193 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry. All patients with stage I to III breast cancer who receive MammaPrint® and BluePrint testing on a primary breast tumor are eligible for entry into the FLEX Registry, which is intended to enable additional study arms at low incremental effort and cost. FLEX Registry will utilize an adaptive design, where additional targeted substudies and arms can be added after the initial study is opened.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Stage I, II, or III patients who receive MammaPrint, with or without BluePrint testing (male or female) * Informed consent form signed on the same day or before enrollment * New primary lesion Exclusion Criteria: * Tumor sample shipped to Agendia with ≤ 30% tumor cells or that fails QA or QC criteria * Metastatic disease * Recurrent disease * Stage 0 disease
💊

What it tests

  • MammaPrint, BluePrint, and Full-Genome Testing
📍

Where

134 sites
CHS Grandview
Birmingham, United States
Providence Alaska Medical Center
Anchorage, United States
Arizona Oncology Associates, PC
Phoenix, United States
Arizona Oncology Associates, PC - HOPE
Tucson, United States
Adventist Health - Bakersfield
Bakersfield, United States
Comprehensive Cancer Center at Desert Regional Medical Center
Palm Springs, United States
North Valley Breast Clinic
Redding, United States
UCSF Breast Care Center
San Francisco, United States

…and 126 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy